Financials
- Fiscal year
- 2024
- Total assets
- €60,246
- Profit
- €22,735
- Solvency
- 62.7%
Total assets▲ 56.6%
Net result
20182024
CARDIOREAMED
ActiveSummary
CARDIOREAMED has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €37,787 and a net result of €22,735. Equity is shrinking by ~3.3% per year across the filed fiscal years. Its solvency ranks better than 45% of 19930 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€60,246total assets 2024
- Equity
- €37,787
- Profit
- €22,735
Turnover not published (abridged schema)
Structure
Accounts 63 d overdue0 of 3 deeds read
Why 96- 1 financial year not filed after the legal deadline; latest accounts 26 days late; 2 of the last 3 late- Figures for FY 2024 (filed 26-08-2025)+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 2.61, cash €34,453Show the evidence
Checked score
Score 2024
96
/ 100
Excellent
Probability in this band: under 0.55%
Better than 69% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency
88-2
equity 62.7% of total assets
Liquidity
83+19
short-term debt 36.9% · cash 57.2%
Profitability
100+4
return on assets 37.7%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 18 months
05-2025: 0.2%
06-2025: 0.2%▲ +3.1% vs 05-2025
07-2025: 0.2%▲ +33.1% vs 06-2025
08-2025: 0.3%▲ +42.1% vs 07-2025highest value
09-2025: 0.1%▼ -71.3% vs 08-2025
10-2025: 0.1%● 0.0% vs 09-2025
11-2025: 0.1%● 0.0% vs 10-2025
12-2025: 0.1%● 0.0% vs 11-2025
01-2026: 0.1%▼ -1.1% vs 12-2025
02-2026: < 0.1%▼ -58.4% vs 01-2026lowest value
03-2026: < 0.1%▲ +8.1% vs 02-2026
04-2026: < 0.1%▼ -2.5% vs 03-2026
05-2026: < 0.1%● 0.0% vs 04-2026
06-2026: < 0.1%▲ +2.6% vs 05-2026
07-2026: < 0.1%▲ +7.5% vs 06-2026
08-2026: 0.1%▲ +34.9% vs 07-2026
09-2026: 0.1%▲ +6.9% vs 08-2026
10-2026: 0.1%▲ +29.0% vs 09-2026
- Sector Human health activities (NACE 86) lowers the probability
- Liquidity: current ratio 2.61, cash €34,453 lowers the probability
- 1 financial year not filed after the legal deadline; latest accounts 26 days late; 2 of the last 3 late raises the probability
- Figures for FY 2024 (filed 26-08-2025) raises the probability
Credit up to €3,500 at 30 days acceptable
Liquidity ample (current ratio 2.61 against 2.4 in 2023; short-term debt: 36.9% and cash: 57.2% of total assets), and 37.3% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 50%, liquidity 66%, profitability 81%, growth against the median 80%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €37,787
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-08-2025, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
26 d late
2023
31 d late
2022
53 d late
2021
on the day
2020
2 d early
2019
46 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 26 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Highest result since 2018net €22,735 ▲167%
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 14
- Since
- 2016
- 26-08-2025Annual accounts filed
- 31-12-2024Highest result since 2018
- 31-08-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 30-07-2008
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.